ZO-Y60 Phase III clinical trial
Phase 3
- Conditions
- Gastrointestinal disease
- Registration Number
- JPRN-jRCT1080221685
- Lead Sponsor
- ZERIA Pharmaceutical Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with gasstrointestinal disease.
Out-patients who signed a written informed consent.
If patient age is under 20 years old, a written informed consent have to be obtained from both participant and his/her parent(s).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method